Bone marrow endothelial cells secrete thymosin β4 and AcSDKP

被引:40
作者
Huang, WQ [1 ]
Wang, QR [1 ]
机构
[1] Cent S Univ, Expt Hematol Lab, Changsha 410078, Hunan, Peoples R China
关键词
thymosin beta 4; AcSDKP; bone marrow endothelial cells; hematopoietic inhibitors;
D O I
10.1016/S0301-472X(00)00634-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Bone marrow endothelial cells are the essential component of the bone marrow microenvironment. They produce many kinds of cytokines, including: stimulators and inhibitors, Many researchers have suggested that in the presence of endothelial cell layer, CD34(+)CD38(-) cells are capable of expansion. The ability of the endothelial cell layer to protect hematopoietic stem cells from extensive differentiation may be related to the inhibitors derived from endothelial cells, The aim of the present study was to determine whether the inhibitors thymosin beta4 and AcSDKP are elaborated by murine bone marrow endothelial cells, Materials and Methods. Murine bone marrow endothelial cells (mBMECs) were cultured in serum-free conditioned medium, Reverse transcriptase polymerase chain reaction (RT-PCR) was used to analyze the differential expression of the thymosin-beta gent, and reverse phase high-performance chromatography (HPLC and mass spectroscopy were used to determine the concentration of thymosin beta4 (T beta4) and AcSDKP in EC lysate and in the medium (mBMEC-CM). Colony-forming unit granulocyte-macrophage (CFU-GM) colony assays were used to examine the effect of components (mw 3-10 kD, <3 kD) of mBMEC-CM, thymosin <beta>4, and AcSDKP on the proliferation of hematopoietic cells. Results. mBMECs expressed T beta3 mRNA, In EC lysate and mBMEC-CM, T beta4 and AcSDKP were detected. After adding protease inhibitors, the concentration of T beta4 in EC lysate increased significantly, while the concentration of AcSDKP decreased. mBMEC-CM (mw 3-10 kD) had no effect on the formation of CFU-GM, How;ever, mBMEC-CM (mw <3 kD) could inhibit the growth of CFU-GM, T<beta>4 (10(-11)similar to 10(-7)mol/L) and AcSDKP (10(-11)similar to 10(-5)mol/L) had dose-dependent inhibitory effects on the growth of CFU-GM, Angiotensin converting enzyme (ACE), the enzyme degrading AcSDKP, could partially eliminate the inhibitory effect of mBMEC-CM (mw <3 kD) on CFU-GM. Conclusion. BMECs express and secrete T<beta>4 and AcSDKP, T beta4 exists in the 3-10 kD component of mBMEC-CM, while AcSDKP exists in the <3 kD component of ECCM, Both components exert inhibitory effects on the proliferation of hematopoietic progenitors. (C) 2001 International Society for Experimental Hematology. Published by Elsevier Science Inc.
引用
收藏
页码:12 / 18
页数:7
相关论文
共 21 条
[11]   INHIBITOR OF HEMATOPOIETIC PLURIPOTENT STEM-CELL PROLIFERATION - PURIFICATION AND DETERMINATION OF ITS STRUCTURE [J].
LENFANT, M ;
WDZIECZAKBAKALA, J ;
GUITTET, E ;
PROME, JC ;
SOTTY, D ;
FRINDEL, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (03) :779-782
[12]   Positive and negative haematopoietic cytokines produced by bone marrow endothelial cells [J].
Li, WM ;
Huang, WQ ;
Huang, YH ;
Jiang, DZ ;
Wang, QR .
CYTOKINE, 2000, 12 (07) :1017-1023
[13]   COMPLETE AMINO-ACID-SEQUENCE OF BOVINE THYMOSIN-BETA-4 - A THYMIC HORMONE THAT INDUCES TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE-ACTIVITY IN THYMOCYTE POPULATIONS [J].
LOW, TLK ;
HU, SK ;
GOLDSTEIN, AL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (02) :1162-1166
[14]  
LOW TLK, 1982, J BIOL CHEM, V257, P1000
[15]  
NAJAGATA H, 1982, P NATL ACAD SCI USA, V79, P3843
[16]  
NILSSON BO, 1990, IMMUNOL TODAY, V11, P1
[17]   INVOLVEMENT OF HUMAN PLASMA ANGIOTENSIN I-CONVERTING ENZYME IN THE DEGRADATION OF THE HAEMOREGULATORY PEPTIDE N-ACETYL-SERYL-ASPARTYL-LYSYL-PROLINE [J].
RIEGER, KJ ;
SAEZSERVENT, N ;
PAPET, MP ;
WDZIECZAKBAKALA, J ;
MORGAT, JL ;
THIERRY, J ;
VOELTER, W ;
LENFANT, M .
BIOCHEMICAL JOURNAL, 1993, 296 :373-378
[18]   Changing patterns of gene expression in developing mouse kidney, as probed by differential mRNA display combined with cDNA library screening [J].
Rosenblum, ND ;
Yager, TD .
KIDNEY INTERNATIONAL, 1997, 51 (03) :920-925
[19]  
Wang QR, 1998, IN VITRO CELL DEV-AN, V34, P443
[20]  
WANG QR, 1997, J EXP HEMATOL, V5, P360